How to Use amyloid in a Sentence

amyloid

noun

• The cause of Alzheimer’s isn’t known, but amyloid is a feature of the disease.
  — The Editorial Board, WSJ, 2 Mar. 2023
• One of the key biomarkers is the amyloid protein, found in plaques.
  — The Conversation, oregonlive.com, 10 Aug. 2019
• If the PET scan was negative, the blood test ruled out amyloid buildup 77% of the time.
  — CBS News, 1 Dec. 2020
• The drug targets amyloid, a protein that clumps in the brains of Alzheimer’s patients.
  — Andrew Williams, The Conversation, 14 Apr. 2022
• The first is plaques made up of one form of amyloid called beta-amyloid.
  — Jason Ulrich, Scientific American, 1 Aug. 2021
• If the PET scan was negative, the blood test ruled out amyloid buildup 77 percent of the time.
  — NBC News, 30 Nov. 2020
• Some look for signs of amyloid; others, tau; still others, the ratio of the two.
  — Tribune News Service, oregonlive, 25 Nov. 2021
• The treatment clears a substance known as amyloid beta from the brain.
  — Jacqueline Howard, CNN, 29 June 2021
• That could mean a blood test to indicate the presence of amyloid.
  — Paula Span, New York Times, 4 Mar. 2024
• Both drugs remove amyloid from the brains of Alzheimer's patients.
  — Ken Alltucker, USA TODAY, 30 July 2024
• The drug works by helping the body remove amyloid plaque buildups in the brain that are a hallmark of Alzheimer’s disease.
  — Alexandra Banner, CNN, 11 June 2024
• The drug slowed declines in both cognitive and day-to-day functions, and reduced the amount of amyloid in the brain.
  — Jason Karlawish, STAT, 6 Oct. 2022
• The scans only turned up beta amyloid in the brain years later.
  — New York Times, 1 Aug. 2019
• It has been shown to reduce a brain protein called amyloid.
  — Star Tribune, 1 Aug. 2021
• In this case, that was Aduhelm’s reduction of amyloid plaque.
  — BostonGlobe.com, 12 June 2021
• In this case, that was Aduhelm’s reduction of amyloid plaques.
  — Globe Staff, BostonGlobe.com, 10 Jan. 2022
• But it is thought the buildup of proteins, such as amyloid plaques and tau tangles, causes damage in the brain.
  — Will Sullivan, Smithsonian Magazine, 1 Dec. 2022
• For decades, many believed that the main cause of Alzheimer’s was a tangled clump of protein in the brain called beta-amyloid.
  — Jacob Siegal, BGR, 11 Dec. 2022
• The drug targets a sticky protein called amyloid that clumps into plaques in the brains of people with Alzheimer’s.
  — BostonGlobe.com, 8 Oct. 2021
• Now, drugs that reduce the buildup of a substance known as amyloid, like Aduhelm, seem more likely to reach the market.
  — Charley Grant, WSJ, 13 June 2021
• The condition is believed to be caused by a buildup of beta amyloid plaques and tau protein in the brain.
  — Katie Hunt, CNN, 29 July 2020
• These therapies may reduce the amount of beta-amyloid formed in the brain.
  — Mayo Clinic News Network, chicagotribune.com, 11 Nov. 2019
• Many researchers believe the beta-amyloid clumps play a key role in Alzheimer’s.
  — Peter Loftus, WSJ, 6 July 2018
• An intense area of study has been the use of antibodies to target amyloid plaques in the brain.
  — Greg Licholai, Forbes, 3 Oct. 2022
• Beta amyloid peptides are protein pieces that form sticky plaques in the brain.
  — Brenda Goodman, CNN, 1 July 2024
• Beta amyloid plaques in the brain are one of the hallmark signals of Alzheimer's, along with tangles of a protein called tau.
  — Sandee Lamotte, CNN, 23 Mar. 2022
• People with the disease have clumps of a protein called amyloid-beta that have built up in those cells.
  — Dallas News, 29 June 2021
• The drug, called Aduhelm, removes amyloid, a sticky substance in the brain that is a defining feature of Alzheimer’s disease.
  — Sumathi Reddy, WSJ, 28 June 2021
• One of the tests was a PET scan designed to determine whether Reinstein has a buildup of amyloid in his brain.
  — Laurie McGinley, Anchorage Daily News, 4 July 2023
• That shows that even when amyloid plaque is removed, the disease continues to progress when a patient stops Leqembi, Eisai said in a release.
  — Annika Kim Constantino, CNBC, 30 July 2024

Last Updated: 13 Nov 2024